ScienceRocks
Democrat all the way!
- Banned
- #1
Trial shows tantalising signs that new Alzheimer's drug could benefit early-stage patients
Injections of the antibody aducanumab appear to slow condition in patients at earliest stages of disease, raising hopes for treatment
Trial shows tantalising signs that new Alzheimer's drug could benefit early-stage patients
The red in the brain scan on the left represents amyloid-beta plaques. At the highest dosage of the treatment being trialled, the brain on the right shows the clearance of plaques. Photograph: Ayres, Michael/Sevigny et al/Nature
Wednesday 31 August 2016 13.00 EDT Last modified on Wednesday 31 August 2016 14.01 EDT
Great...
Injections of the antibody aducanumab appear to slow condition in patients at earliest stages of disease, raising hopes for treatment
Trial shows tantalising signs that new Alzheimer's drug could benefit early-stage patients
The red in the brain scan on the left represents amyloid-beta plaques. At the highest dosage of the treatment being trialled, the brain on the right shows the clearance of plaques. Photograph: Ayres, Michael/Sevigny et al/Nature
Wednesday 31 August 2016 13.00 EDT Last modified on Wednesday 31 August 2016 14.01 EDT
A trial of a new Alzheimer’s drug has shown it could benefit patients in the earliest stages of the disease, raising hopes that a treatment for the devastating condition may finally be on the horizon.
While the trial was designed to assess the safety of the treatment and not whether patients fared better on the drug, an “exploratory analysis” of the data revealed that the treatment appeared to slow the mental decline of patients who responded to the therapy.
Great...